Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC

• Main Authors: Luca Cantini (Author), Federica Pecci (Author), Filippo Merloni (Author), Andrea Lanese (Author), Edoardo Lenci (Author), Francesco Paoloni (Author), Joachim G.J.V. Aerts (Author), Rossana Berardi (Author)
• Format: Book
• Published: Open Exploration Publishing Inc., 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The introduction of immune checkpoint inhibitors (ICIs) in non-oncogene addicted non-small cell lung cancer (NSCLC) has revolutionized the treatment scenario and led to a meaningful improvement in patient prognosis. Disappointingly, the success of ICI therapy in NSCLC has not been fully replicated i...